For the second year in a row, Dion Paridaens gave a series of lectures at the 2019 ESASO Course on Orbital, Lacrimal & Oculoplastic Surgery Course in Lugano, Switzerland (21–25 January, 2019).
Epi-on CXL aims to sidestep epi-off CXL’s issues by leaving the epithelium intact, however, this comes at a price of reduced efficacy – no clinical trial published to date has convincingly shown epi-on CXL to be as effective as epi-off CXL at the most important outcome: stopping keratoconus from progressing.
What is the future of corneal cross-linking (CXL)? PACK-CXL to treat corneal infections without antibiotics, refractive cross-linking and better Kpros…
The Cornea Society published a best practice review of CXL in the USA. Cross-linking is relatively new to the USA (but not Europe) – let’s get up to speed.
The Cornea Society published a best practice review of CXL in the USA. Cross-linking is relatively new to the USA (but not Europe) – let’s get up to speed.
Being appointed FARVO – Fellow of the Association for Research in Vision and Ophthalmology – is a big deal for me. Let me tell you why…
The Cross-Linking Experts 2018 Meeting 2018 Zurich, organised by the Light for Sight Foundation, took place in Zurich for the 14th consecutive time
ELZA in Tunisia: ELZA founder Farhad Hafezi gives several lectures in Sousse at the Annual Meeting of ATMO
EyeWorld’s Jonathan Kahn interviews Farhad Hafezi on a new method that might improve the efficacy of corneal cross-linking for the treatment of corneal ectasias like #keratoconus: cooling the cornea!
Swiss ophthalmologist receives an award in Russia: The ophthalmologist Farhad Hafezi from the ELZA Institute gave the honorary lecture at the renowned Fyodorov Microsurgery Eye Institute in Moscow
